NANOVIRICIDES, INC. Loans Payable
NANOVIRICIDES, INC. (NNVC) had Loans Payable of $0 as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LoansPayable · last filed 2023-10-13
- 2023-03-31: Loans Payable $0.00.
- 2022-12-31: Loans Payable $0.00.
- 2022-09-30: Loans Payable $23.84K.
- 2022-06-30: Loans Payable $94.79K.
| Period end | Loans Payable |
|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $0.00 10-Q · filed 2023-02-14 |
| 2022-09-30 | $23.84K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $94.79K 10-K · filed 2023-10-13 |
| 2022-03-31 | $164.91K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $0.00 10-Q · filed 2022-02-14 |
| 2021-09-30 | $23.97K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $95.31K 10-K · filed 2022-10-13 |
| 2021-03-31 | $165.81K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $0.00 10-Q · filed 2021-02-16 |
| 2020-09-30 | $15.81K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $62.84K 10-K · filed 2021-10-12 |
| 2020-03-31 | $109.30K 10-Q · filed 2020-06-22 |
| 2019-06-30 | $0.00 10-K · filed 2020-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |